Last week we announced the launch of TDScreen – our AI-powered Tardive Dyskinesia (TD) screening tool. The response has been immediate and overwhelming, validating everything we believed about the urgent need for accessible TD screening.
This is exactly why we built TDScreen.
The Hidden Crisis in Plain Sight
Let me share some numbers that keep me up at night:
- At least 500,000 Americans suffer with Tardive Dyskinesia
- Only 20% of those have been diagnosed
- That’s a 80% diagnosis gap
But here’s what those statistics don’t capture: Each untreated case represents someone whose involuntary movements might be dismissed as nervousness, aging, or “just a quirk.” Someone who might stop taking life-changing medications because they’re embarrassed by movements that could be managed. Someone whose quality of life is quietly deteriorating while effective treatments exist.
Why Traditional Screening Fails
The standard AIMS assessment takes 15-20 minutes of specialized clinical time. For a psychiatrist seeing 20-30 patients daily, screening everyone quarterly (as guidelines recommend) is mathematically impossible. It’s not about clinician dedication – it’s about the brutal reality of time constraints in modern healthcare.
This is where AI changes everything. TDScreen compresses expert-level assessment into a 5-minute patient self-assessment, with accuracy that actually exceeds human raters (0.89 AUC, validated in our Journal of Clinical Psychiatry study).
The Business Decision to Make TDScreen Free
We’re not in the business of gatekeeping essential healthcare tools. We’re in the business of transforming behavioral health outcomes.
Making TDScreen free isn’t charity – it’s strategy. Every provider who adopts TDScreen becomes part of our mission to modernize behavioral healthcare. Every patient who gets screened is a potential life improved. And every success story builds the foundation for our broader platform vision.
What Our TD Screening Tool Actually Does
For providers wondering about the specifics – here’s exactly what you get:
Immediate Clinical Value
- Patient completes video assessment (smartphone, tablet, or computer)
- AI analyzes movement patterns based on AIMS criteria
- You receive an objective risk score with visual highlights
- Track changes over time with quantitative data
Zero Hidden Costs
- No subscription fees
- No per-patient charges
- No training requirements
- No IT integration needed
- Start screening in under 15 minutes
The Evidence Behind TDScreen
Our research, published yesterday in the Journal of Clinical Psychiatry, demonstrates that TDScreen achieves:
- Superior consistency compared to human raters (Cohen’s Kappa of 0.61)
- Validated across 350+ patients in multi-site clinical trials
This isn’t theoretical – it’s proven technology ready for clinical use today. Our partners in the study – Dr. Anthony A. Sterns, Ph.D., lead researcher on the project and CEO at iRxReminder, Dr. Owen Muir, CMO of iRxReminder, CMO and co-founder of Radial Health, and co-author of the publication, and the National Institutes of Health – provided the data and analysis that helped to create TDScreen.
The Bigger Vision
Why This TD Screening Tool Changes Everything
TDScreen is just the beginning. At Videra Health, we’re building a comprehensive AI platform that transforms how behavioral health providers deliver care. But we started with TD screening for a reason: it’s a massive, solvable problem where AI demonstrably outperforms traditional methods.
By making TDScreen free, we’re proving that AI in healthcare doesn’t have to be expensive, complex, or intimidating. It can be as simple as sending your patient a link.
Your Patients Are Waiting
If you prescribe antipsychotics, you have patients at risk for TD. Statistically, several already have symptoms. The question isn’t whether to screen – it’s whether you’ll do it the old way or the better way.
TDScreen is live, validated, and free at tdscreen.ai.
No sales calls. No demos required. No contracts to sign.
Just better care, starting today.
Join the Movement
In healthcare innovation, the best time to adopt new technology is when it’s proven but not yet universal. TDScreen has the validation (peer-reviewed research), the accessibility (completely free), and the simplicity (5-minute assessments) to transform TD screening.
The providers who adopt TDScreen today aren’t just using a tool – they’re setting a new standard of care for their patients.
Will you join us?
Start screening at tdscreen.ai